(Q48695359)

14 February 2018

title

Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution. (English)

1 reference

14 February 2018

0 references

0 references

3

1 reference

14 February 2018

José Antonio Del Río

5

1 reference

14 February 2018

Rosalina Gavín

6

1 reference

14 February 2018

Lara Ordóñez-Gutiérrez

object named as

L Ordóñez-Gutiérrez

2

0 references

author name string

C Vergara

1

1 reference

14 February 2018

I Ferrer

4

1 reference

14 February 2018

publication date

26 June 2014

1 reference

14 February 2018

published in

Molecular Neurobiology

1 reference

14 February 2018

volume

51

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

1206-1220

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s12035-014-8793-7

exact match

0 references

cites work

Expression of PrP(C) in the rat brain and characterization of a subset of cortical neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Selective expression of prion protein in peripheral tissues of the adult mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Developmental expression of the prion protein gene in glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The cellular prion protein (PrP(C)): its physiological function and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Novel proteinaceous infectious particles cause scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prions: protein aggregation and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Tau aggregation into fibrillar polymers: taupathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Role of tau protein in both physiological and pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cdk5 deregulation in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Memory impairment in transgenic Alzheimer mice requires cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Phosphorylation of tau by fyn: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The cellular prion protein and its role in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Regulation of amyloid-β production by the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Tau isoform regulation is region- and cell-specific in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Animal models reveal role for tau phosphorylation in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Pin1 affects Tau phosphorylation in response to Abeta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Signal transduction through prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Context dependent neuroprotective properties of prion protein (PrP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Propagation of tau pathology in a model of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein (PrPc) promotes beta-amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Intracellular and extracellular tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Tau pathology and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein is a component of the multimolecular signaling complex involved in T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8793-7

Prion protein expression in senile plaques in Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway

1 reference

12 December 2020

The protein tyrosine kinase, fyn, in Alzheimer's disease pathology.

1 reference

12 December 2020

Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau

1 reference

12 December 2020

Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration

1 reference

12 December 2020

Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity

1 reference

12 December 2020

Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

1 reference

12 December 2020

Altered intracellular distribution of PrPC and impairment of proteasome activity in tau overexpressing cortical neurons.

1 reference

12 December 2020

Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice.

1 reference

12 December 2020

Evolution of Alzheimer's disease related cortical lesions.

1 reference

12 December 2020

Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Oxidative stress and the pathogenesis of Alzheimer's disease

1 reference

12 December 2020

Impact of the cellular prion protein on amyloid-β and 3PO-tau processing

1 reference

12 December 2020

Evolution of the neuropathology of Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12035-014-8793-7

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

24965601

1 reference

14 February 2018